Universal Health Services, Inc. (NYSE:UHS - Free Report) - Analysts at Leerink Partnrs issued their Q1 2026 EPS estimates for shares of Universal Health Services in a report released on Thursday, February 27th. Leerink Partnrs analyst W. Mayo expects that the health services provider will earn $5.07 per share for the quarter. The consensus estimate for Universal Health Services' current full-year earnings is $15.92 per share. Leerink Partnrs also issued estimates for Universal Health Services' Q3 2026 earnings at $4.33 EPS and Q4 2026 earnings at $5.46 EPS.
Universal Health Services (NYSE:UHS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The health services provider reported $4.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.21 by $0.71. The business had revenue of $4.11 billion for the quarter, compared to the consensus estimate of $4.01 billion. Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%.
Several other brokerages also recently weighed in on UHS. StockNews.com downgraded shares of Universal Health Services from a "strong-buy" rating to a "buy" rating in a research note on Saturday, November 9th. Bank of America started coverage on shares of Universal Health Services in a research report on Wednesday, November 6th. They issued a "neutral" rating and a $223.00 price objective on the stock. Cantor Fitzgerald raised Universal Health Services from a "neutral" rating to an "overweight" rating in a research note on Monday, February 3rd. TD Cowen dropped their price objective on Universal Health Services from $275.00 to $251.00 and set a "buy" rating for the company in a report on Tuesday, November 26th. Finally, The Goldman Sachs Group downgraded Universal Health Services from a "buy" rating to a "neutral" rating and cut their price objective for the company from $228.00 to $198.00 in a research report on Monday, December 16th. Six investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $228.77.
View Our Latest Analysis on UHS
Universal Health Services Trading Up 0.2 %
NYSE:UHS traded up $0.28 during midday trading on Monday, hitting $175.53. 1,075,868 shares of the company traded hands, compared to its average volume of 647,532. The company has a current ratio of 1.39, a quick ratio of 1.28 and a debt-to-equity ratio of 0.69. The firm's fifty day moving average is $184.47 and its 200-day moving average is $204.80. The firm has a market capitalization of $11.58 billion, a P/E ratio of 11.67, a P/E/G ratio of 0.53 and a beta of 1.30. Universal Health Services has a 12-month low of $152.68 and a 12-month high of $243.25.
Universal Health Services Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be paid a dividend of $0.20 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.46%. Universal Health Services's dividend payout ratio is presently 4.75%.
Insider Activity
In other Universal Health Services news, Director Maria Ruderman Singer sold 1,614 shares of the company's stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $191.15, for a total transaction of $308,516.10. Following the completion of the sale, the director now owns 5,879 shares in the company, valued at $1,123,770.85. This represents a 21.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 16.10% of the company's stock.
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the stock. R Squared Ltd purchased a new position in Universal Health Services in the fourth quarter valued at about $29,000. True Wealth Design LLC bought a new stake in shares of Universal Health Services in the 3rd quarter valued at about $39,000. Quent Capital LLC grew its position in shares of Universal Health Services by 118.3% in the 4th quarter. Quent Capital LLC now owns 179 shares of the health services provider's stock worth $32,000 after buying an additional 97 shares during the last quarter. Huntington National Bank raised its stake in shares of Universal Health Services by 414.3% during the 3rd quarter. Huntington National Bank now owns 180 shares of the health services provider's stock worth $41,000 after acquiring an additional 145 shares in the last quarter. Finally, Campbell Capital Management Inc. purchased a new stake in Universal Health Services during the fourth quarter valued at approximately $46,000. 86.05% of the stock is owned by institutional investors.
About Universal Health Services
(
Get Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
Further Reading

Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.